SCHEMBL19950447

SCHEMBL19950447

Nc1ccc(O)c(N2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.61
NFKB1 P19838 1/20 0.61
PMP22 Q01453 1/20 0.61
TYMS P04818 1/20 0.51
NR1H3 Q13133 5/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
SCN2A Q99250 2/20 0.45
NR1H2 P55055 2/20 0.44
ANPEP P15144 2/20 0.44
DPP4 P27487 1/20 0.44
NPC1 O15118 3/20 0.43
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 3/20 0.43
TSHR P16473 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PIM3 Q86V86 1/20 0.43
HIPK4 Q8NE63 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9240516 0.86 CYP3A4 (0.66) CYP3A4NFKB1PMP22TYMSNR1H3
Hydrochloric Acid SCHEMBL29690161 0.85 CYP3A4 (0.64) CYP3A4NFKB1PMP22TYMSNR1H3
SCHEMBL6005895 0.82 ESR1 (0.62) TYMSNR1H3ESR1ESR2SCN2A
SCHEMBL18917454 0.82 CYP3A4 (0.65) CYP3A4NFKB1PMP22NR1H3SCN2A
SCHEMBL12733162 0.81 ESR1 (0.51) CYP3A4NFKB1PMP22TYMSNR1H3
SCHEMBL18806460 0.79 CYP3A4 (0.61) CYP3A4NFKB1PMP22NR1H3SCN2A
SCHEMBL30268221 0.78 TYMS (0.72) TYMSNR1H3ESR1ESR2SCN2A
SCHEMBL2150841 0.77 MEN1 (0.55) NR1H3ESR1ESR2SCN2ANR1H2
SCHEMBL8995310 0.77 CYP3A4 (0.62) CYP3A4NFKB1PMP22NR1H3ESR1
SCHEMBL5924351 0.76 CYP3A4 (0.66) CYP3A4NFKB1PMP22NR1H3ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9981905-B2 Aromatic diamine, an intermediate therefor, a method for producing the aromatic diamine, and a method for producing the intermediate therefor SEIKA CORPORATION (JP) 2018-05-29 US disclosed
US-20180072655-A1 AROMATIC DIAMINE, AN INTERMEDIATE THEREFOR, A METHOD FOR PRODUCING THE AROMATIC DIAMINE, AND A METHOD FOR PRODUCING THE INTERMEDIATE THEREFOR SEIKA CORPORATION (JP) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072655-A1 AROMATIC DIAMINE, AN INTERMEDIATE THEREFOR, A METHOD FOR PRODUCING THE AROMATIC DIAMINE, AND A METHOD FOR PRODUCING THE INTERMEDIATE THEREFOR ALDH7A1, ODC1, ASS1 CYP3A4 627/4885NFKB1 1120/4885PMP22 3480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.